|Articles|November 21, 2019
Challenging Microbial Sanitization of a Liquid Chromatography System
To ensure that no contaminating or hazardous residual components remain after protein purification during biologic development, additional sanitization steps may be required for the instrumentation utilized during these processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
4
Streamlining Procurement and Inventory Management Leads to Increased Productivity
5
